[NBY] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
26-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -1,136.17%
YoY- -174.92%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 3,643 2,641 1,888 1,704 3,625 6,316 4,077 -1.85%
PBT -8,206 -158 -1,750 -2,683 -1,265 795 -1,648 30.66%
Tax -3,488 735 4 3 3 2 -4 208.93%
NP -8,206 -893 -1,754 -3,486 -1,268 793 -1,648 30.66%
Tax Rate - - - - - -0.25% - -
Total Cost 11,849 3,534 3,642 5,190 4,893 5,523 5,725 12.88%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -225.25 -33.81 -92.90 -204.58 -34.98 12.56 -40.42 33.13%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -4.33 -0.69 -1.47 -4.42 -2.60 1.69 -3.78 2.28%
EPS Diluted -4.33 -0.69 -1.47 -4.42 -2.60 1.69 -3.77 2.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.